Life Sciences

Too often Unicorns lack meaningful IP protection and that makes them vulnerable to attack

A billion dollar valuation is all well and good, but many stellar start-ups risk being burned by having to pay-out big money to fend off patent infringement suits

Too often Unicorns lack meaningful IP protection and that makes them vulnerable to attack
21 Aug 2019

New written description rule set out by Federal Circuit in precedential Contrave judgment

Appellate court’s decision to uphold patent on weight loss treatment seems to create more flexible requirements.

19 Aug 2019

For high-cost, high-value patents, fixed-fee procurement could be the answer

A subscription model to cover the application process may well be the best way to make increased expenditure on securing portfolio-enhancing rights more palatable

Latest

View all
16 Aug 2019

AstraZeneca faces increasingly tough evergreening battle in India

A recent Delhi court decision is a reminder of the tight restrictions around species and follow-on patents in the country Read more

15 Aug 2019

Why the future of patent pools is a case of "it depends"

There are circumstances under which the model can definitely work, but these may not apply to all industries and might mean licensors having to modify their financial expectations Read more

13 Aug 2019

CAFC closes off another defence against inter partes review

IPR cancellations of pre-AIA rights are not unconstitutional takings under Fifth Amendment, Federal Circuit rules Read more

8 Aug 2019

Key pharma and agrochemical patents under threat in Brazil after court ruling

Owners face having the terms of their so-called mailbox rights reduced after decision overturns rules designed to counter chronic applications backlog at the country’s IP office Read more

News

View all
3 Aug 2019

Life sciences IP – the major developments in July

All the big pharma and biotech patent stories from last month in our regular monthly round-up Read more

1 Aug 2019

Users like the EPO’s services - but there is still room to improve, according to new report

The annual assessment of the office’s performance finds that that satisfaction rates are up, but timeliness remains a problem Read more

26 Jul 2019

Switzerland once again named as the world’s most innovative country

New research finds that Europe is ahead of the rest when it comes to the quality of innovations and also leads in filing international patents Read more

18 Jul 2019

Federal Circuit decision shows door not shut on infringement claims under the doctrine of equivalents in ANDA cases

Ruling in UCB v Watson Laboratories provides important strategic guidance on the doctrine for both patent prosecutors and litigators Read more

Analysis

View all
6 Aug 2019

Canadian IP initiative aims to kick-start a revolution

Although it is home to many big ticket patent players, Canada has lagged in encouraging SMEs to maximise the value of the rights they own; new programme designed to reverse that trend Read more

6 Aug 2019

Record-breaking pharma M&A value disguises plummeting deal-making activity

Abundant biotech funding seems to be empowering small- and medium-sized IP rights holders and driving down acquisition and licensing volume Read more

5 Aug 2019

CAFC creates blueprint for early stage challenges to claims brought under doctrine of equivalents

Amgen’s infringement suit was barred by prosecution history estoppel as the Federal Circuit affirmed district court’s Rule 12(b)(6) dismissal Read more

5 Aug 2019

China seeks to boost IP lending

Companies staked patents and trademarks to borrow $8.5 billion in the first half of 2019. CNIPA and China’s banking regulator want that figure to increase as SMEs face a credit squeeze Read more

Insights

View all
24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more

1 Apr 2019

IP market news highlights

The big stories from the IAM platform in February and March. Read more